Atlas Trials

Sequential Treatment of CD20-positive Posttransplant Lymphoproliferative Disorder (PTLD)

Clinical trial NCT01458548 · TERMINATED

Trial details

NCT number
NCT01458548
Sponsor
Charite University, Berlin, Germany
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Post-transplantation Lymphoproliferative Disorder
Start date
2002-12-01
Primary completion
2008-05-01
Enrollment
70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.